Search

everythinglearnresearchcommunity

for

Search:↓

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Immune therapy for cancer can cause hair loss scars in some patients.

Immunological treatment improved both neuropathy and alopecia.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

MicroRNAs are crucial for controlling skin development and healing by regulating genes.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Minoxidil may help hair regrowth in alopecia areata by affecting T-cells.

ILC1-like cells may contribute to hair loss in alopecia areata.